Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01776398
What this trial is testing

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3 more
Weill Medical College of Cornell University 2,000
Early research (Phase 1)Study completedNCT01254409
What this trial is testing

A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 21
Not applicableWithdrawnNCT05676112
What this trial is testing

Safety of Nintedanib in Real World in China

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim
Testing effectiveness (Phase 2)Ended earlyNCT06097260
What this trial is testing

Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 320
Testing effectiveness (Phase 2)UnknownNCT04805086
What this trial is testing

The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseCovid19
Guy's and St Thomas' NHS Foundation Trust 5
Testing effectiveness (Phase 2)UnknownNCT05181397
What this trial is testing

The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases

Who this might be right for
Rapid Progressive Interstitial Lung Diseases
Peking Union Medical College Hospital 68
Not applicableStudy completedNCT03462524
What this trial is testing

Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

Who this might be right for
Esophageal CancerRadiation PneumonitisPulmonary Fibrosis+8 more
St. James's Hospital, Ireland 384
Not applicableLooking for participantsNCT07300696
What this trial is testing

Functional MRI for Monitoring Progression and Assessing Trends in ILD

Who this might be right for
Interstitial Lung Diseases (ILD)
University Hospital Heidelberg 200
Not applicableNot Yet RecruitingNCT07173582
What this trial is testing

"Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease"

Who this might be right for
Rheumatoid Arthritis (RA)
Assiut University 81
Not applicableActive Not RecruitingNCT07571291
What this trial is testing

DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS

Who this might be right for
Pulmonary Fibrosis
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Testing effectiveness (Phase 2)Looking for participantsNCT06951217
What this trial is testing

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Who this might be right for
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc. 340
Not applicableStudy completedNCT02055222
What this trial is testing

Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease

Who this might be right for
Pulmonary FibrosisLung Disease
National Heart, Lung, and Blood Institute (NHLBI) 7
Large-scale testing (Phase 3)UnknownNCT04773366
What this trial is testing

A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol

Who this might be right for
Langerhans Cell Histiocytosis
Shanghai Children's Medical Center 200
Not applicableStudy completedNCT01134822
What this trial is testing

Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Nottingham 330
Testing effectiveness (Phase 2)UnknownNCT02543073
What this trial is testing

MSC for Treatment of Interstitial Lung Disease After Allo-HSCT

Who this might be right for
Lung Diseases, InterstitialHematopoietic Stem Cell TransplantationBronchiolitis Obliterans
Nanfang Hospital, Southern Medical University 60
Not applicableStudy completedNCT04978883
What this trial is testing

Interstitial Lung Diseases in Primary Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
Second Affiliated Hospital, Zhejiang University, School of Medicine 170
Testing effectiveness (Phase 2)Ended earlyNCT06360094
What this trial is testing

Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 85
Not applicableStudy completedNCT05311345
What this trial is testing

Integration of Cryobiopsies for ILD Diagnoses- Experience Based on 250 Biopsy Procedures.

Who this might be right for
Interstitial Lung Disease
Aarhus University Hospital 250
Testing effectiveness (Phase 2)UnknownNCT05758571
What this trial is testing

Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients

Who this might be right for
Interstitial PneumoniaNeoplasms Malignant
Shandong Cancer Hospital and Institute 78
Not applicableStudy completedNCT04930666
What this trial is testing

BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease

Who this might be right for
Pulmonary Disease, Chronic ObstructiveLung Diseases, Interstitial
Columbia University 30
Next Page